Strategic Partnerships Potential sales opportunities exist with international distributor Nipro Corporation for the Japanese market, expanding Orchid Safety Release Valve (SRV) reach and leveraging their established hospital channels.

Key Executive Recent appointment of Dr. Robert C. Robbins as Chief Medical Officer and board member may open doors with clinical decision‑makers and hospital networks, enabling higher trust and expedited evaluations of Orchid SRV in clinical settings.

Market Demand Orchid SRV addresses IV catheter dislodgement and related waste, a multi‑billion‑dollar inefficiency in U.S. healthcare, highlighting a large, addressable market for hospitals focused on reducing waste and improving patient safety.

Global Expansion Existing distribution across North America and now targeted entry into Japan suggests opportunity to pursue additional regional partnerships or GPO collaborations to accelerate hospital adoption and line‑item procurement.

Evidence & Recognition Previous innovative technology awards and ongoing press coverage support credibility with procurement teams; leverage current accolades to accelerate RFP responses and budget approvals in hospital systems and distributors.